Literature DB >> 16260181

Safety issues regarding new vaccines for tuberculosis, with an emphasis on post-exposure vaccination.

Ian M Orme1.   

Abstract

There are several new types of vaccines that have become potential candidates for the prevention of tuberculosis. While these have been tested in the conventional animal models, less emphasis has been placed as yet on the development of safety testing procedures. This is particularly important if we are ever going to use such vaccines in a therapeutic or post-exposure mode, in which the risk of severe "Koch-like" reactions may be high. A further element that badly needs more research is the state of immunity already preexisting in the infected host and how vaccine induced immunity may interact with this.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260181     DOI: 10.1016/j.tube.2005.07.002

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  4 in total

Review 1.  Tuberculosis vaccine types and timings.

Authors:  Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

2.  Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis.

Authors:  Crystal A Shanley; Gregory C Ireton; Susan L Baldwin; Rhea N Coler; Steven G Reed; Randall J Basaraba; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2013-09-07       Impact factor: 3.131

3.  Animal models of mycobacteria infection.

Authors:  I M Orme; A D Roberts
Journal:  Curr Protoc Immunol       Date:  2001-05

4.  Exosomes carrying mycobacterial antigens can protect mice against Mycobacterium tuberculosis infection.

Authors:  Yong Cheng; Jeffery S Schorey
Journal:  Eur J Immunol       Date:  2013-09-06       Impact factor: 5.532

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.